News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chiron Vaccines (CHIR) Release: SBL Vaccines Management Group To Acquire Swedish Operations


10/19/2005 5:11:14 PM

Chiron Vaccines, a business unit of California-based Chiron Corporation Inc, announces today that its Swedish management team will acquire its SBL Vaccines operations in Sweden. Under the terms of the agreement SBL Vaccines will go forward as an independent Swedish company, backed by the leading venture capitalists 3i Plc and SEB Företagsinvest. The business will continue to be run by the existing management group led by Björn Sjöstrand, and will use the long-established SBL name. In consideration for the Swedish operations, SBL Vaccines will grant Chiron Vaccines marketing rights in the key European markets to its recently approved oral cholera vaccine, Dukoral®.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES